Beijing SL Pharmaceutical Co (SZSE:002038) Total Long-Term Liabilities : ¥104.4 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Beijing SL Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Beijing SL Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥104.4 Mil.

Beijing SL Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Beijing SL Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing SL Pharmaceutical Co Total Long-Term Liabilities Chart

Beijing SL Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

95.12

109.28

107.77

94.40

108.97

Beijing SL Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial															83.34	73.92	68.89	108.97	104.44

Beijing SL Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Beijing SL Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing SL Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing SL Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing SL Pharmaceutical Co Ltd (SZSE:002038) » Definitions » Total Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No.69 Fu shi Road, No.1 Building, Bitongyuan, Haidian district, Beijing, CHN, 100049

Website

http://www.slpharm.com.cn

Beijing SL Pharmaceutical Co Ltd is a Chinese biotechnology-pharmaceutical company. It is principally focused on developing and marketing gene engineering drugs. The product portfolio of the company includes drugs for Oncology, Hepatopathy and Senile disease. Its products include Filgrastim, Asparaginase, Dasartinib, Enoxaparin, Naftopidil, Ademetionine, Lenalidomide, and others.

Executives

Liang Shu Jie	Secretary, Director
Xu Ming Bo	Directors, executives
Yang Zhong Fan	Supervisors
Chen Yu Lin	Director
Qi Yan Ming	Supervisors
Xi Wen Ying	Executives
Wu Yan Zhuo	Executives
Wang Wen Xin	Director
Li Ya Jun	Executives
Zhao Xia	Securities Affairs Representative
Zhang Chun Lei	Supervisors
Wang Yong Bo	Directors, executives
Lu An Jing	Supervisors
Wei Su Yan	Director

Beijing SL Pharmaceutical Co Headlines

No Headlines